Pacific Rim Ventures logo

Pacific Rim Ventures

North America, California, United States, San Francisco

Description

Pacific Rim Ventures is focused on investing in life science companies with a global focus.

Investor Profile

Pacific Rim Ventures has made 7 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series C (29%)
  • Debt Financing (14%)
  • Series B (14%)
  • Series D (14%)
  • Series Unknown (14%)
  • Series A (14%)

Country Focus

  • United States (86%)
  • United Kingdom (14%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Biopharma
  • Therapeutics
  • Clinical Trials
  • Software
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Pacific Rim Ventures frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 2
Abingworth
Europe, England, United Kingdom, London
Co-Investments: 2
H&
North America, Massachusetts, United States, Boston
Co-Investments: 2
MPM Capital
North America, Massachusetts, United States, Boston
Co-Investments: 2
Carnegie
Europe, Stockholms Lan, Sweden, Stockholm
Co-Investments: 1
WestRiver Group
North America, Washington, United States, Kirkland
Co-Investments: 2
Anthem Venture Partners
North America, California, United States, Santa Monica
Co-Investments: 1
Burrill & Company
North America, California, United States, San Francisco
Co-Investments: 2
BS
North America, New York, United States, New York
Co-Investments: 1
MDS Capital
North America, New York, United States, New York
Co-Investments: 2

Which angels does Pacific Rim Ventures often collaborate with?

AZ
North America, California, United States, Mountain View
Shared Deals: 1

What are some of recent deals done by Pacific Rim Ventures?

Tranzyme

Durham, North Carolina, United States

Tranzyme Pharma is a biopharmaceutical company focused on the discovery, development, and commercialization of mechanism-based therapies.

BiotechnologyMedicalTherapeutics
Series AMay 13, 2005
Alexza Pharmaceuticals

Mountain View, California, United States

Alexza Pharmaceuticals is a pharmaceutical company developing novel products for the treatment of acute and intermittent conditions.

BiotechnologyHealth CarePharmaceutical
Series DJan 6, 2005
Amount Raised: $52,000,000
Idun Pharmaceuticals

San Diego, California, United States

IDUN Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of human therapeutics to control

BiopharmaBiotechnologyTherapeutics
Series BJun 15, 2004
Amount Raised: $27,000,000
Corus Pharma

Seattle, Washington, United States

Corus Pharma Inc., a Seatle-based biotech and specialty drug company focused on respiratory and infectious diseases.

BiotechnologyHealth CarePharmaceutical
Series CApr 13, 2004
Amount Raised: $65,000,000
Bacterial Barcodes

Houston, Texas, United States

Bacterial BarCodes, Inc., seeks to serve the clinical diagnostic market for bacterial identification.

BiotechnologyClinical TrialsSoftware
Series CFeb 12, 2003
Amount Raised: $6,000,000
Oxagen

London, England, United Kingdom

Oxagen is a biopharmaceutical company developing small molecule drugs addressing asthma, and chronic allergic and inflammatory conditions.

BiopharmaBiotechnologyHealth CarePharmaceutical
Series UnknownDec 21, 2000
Amount Raised: $44,240,218
Acadia Pharmaceuticals Inc.

San Diego, California, United States

Acadia Pharmaceuticals develops and commercializes small molecule drugs for the treatment of central nervous system disorders.

BiotechnologyHealth CarePharmaceutical
Debt FinancingJun 20, 2000
Amount Raised: $22,000,000